Log in or Sign up for Free to view tailored content for your specialty!
Therapeutics News
Brinzolamide-brimonidine fixed combination provides effective IOP control
Fixed-combination brinzolamide 1% and brimonidine 0.2% was safe and effective at lowering IOP over a 24-hour period in a prospective, multicenter trial.
Biologics effective against nonresponding Sjögren’s syndrome
SAN ANTONIO – More than 200 biologic agents are available, and their use is becoming more common in eye care, Casey L. Hogan, OD, FAAO, FSLS, said here at the Anterior Segment Section Symposium during the American Academy of Optometry meeting.
Log in or Sign up for Free to view tailored content for your specialty!
Oyster Point announces positive results with dry eye drugs
Oyster Point Pharma announced that studies of its novel therapies for treating dry eye demonstrated improvement in Schirmer’s score and multiple measures of eye dryness symptoms.
Clinician discusses drug penetration technology in Inveltys
SAN ANTONIO – Walter Whitley, OD, MBA, FAAO, discusses the amplified technology behind Inveltys that helps the drug penetrate the eye.
SLT shows efficacy as first line, adjunctive therapy in POAG
Selective laser trabeculoplasty is equally effective at lowering intraocular pressure when used in treatment naïve, newly diagnosed eyes with primary open angle glaucoma (POAG) or as an adjunctive treatment in eyes with medically uncontrolled disease, according to a study.
Higher doses of sildenafil citrate can lead to prolonged retinal damage
At high dosage, sildenafil citrate can lead to persistent retinal toxicity in certain individuals, according to a case report.
No IOP change after switching to latanoprost/carteolol fixed combination
Switching patients with primary open-angle glaucoma or ocular hypertension from concomitant latanoprost and carteolol HCL to a latanoprost/carteolol fixed combination led to similar IOP control and good patient satisfaction.
Eyevance acquires Flarex from Novartis
Eyevance Pharmaceuticals announced the acquisition of Flarex from Novartis AG.
Latanoprost shows long-term safety in pediatric patients
Latanoprost showed an acceptable safety profile in a cohort of children with glaucoma and elevated IOP.
PCON sponsors AAO courses on health care delivery, biologics
Primary Care Optometry News will co-sponsor two courses at the American Academy of Optometry annual meeting in San Antonio.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read